Table 2.
Baseline patient characteristics.
Study | Total Patients | Age | Males | Hypertension | Diabetes | Cardiovascular Disease | Renal Disease | Respiratory Disease |
---|---|---|---|---|---|---|---|---|
Elmunzer BJ et al., 2021 [22]; North America | 1846 | Mean 59.9 SD 16.4 | 1044 (56.6%) | 1146 (62.1%) | 658 (35.6%) | 478 (25.9%) | 175 (9.48%) | 368 (20.0%) |
Almario CV et al., 2020 [16]; America | 3386 | N/A | 1168 (34.5%) | N/A | 243 (7.2%) | N/A | N/A | N/A |
Lee SW et al., 2020 [23]; Korea | 4785 | Mean 45.4 SD 18.8 | 1893 (44.7%) | 945 (19.8%) | 524 (11.0%) | 263 (5.5%) | 150 (3.1%) | 523 (11.0%) |
Israelsen SB et al., 2021 [15]; Denmark | 4473 | Median 60 IQR 48–73 | 1989 (44.5%) | N/A | 564 (12.6%) | 832 (18.6%) | 231 (5.2%) | 560 (12.6%) |
Liu JJ et al., 2021 [24]; Mississippi | 56 | Mean 58 SD 14 | 20 (35.7%) | 39 (69.6%) | 24 (43.6%) | 3 (5.4%) | 7 (17.9%) | N/A |
Fan X et al., 2021 [19]; United Kingdom | 9469 | >65 | 4611 (48.7%) | N/A | 1226 (12.9%) | 1741 (18.3%) | 753 (7.9%) | 1738 (18.3%) |
Zhou J et al., 2021 [26]; China | 4445 | Median 44.8 | 307(58.6%) | 209 (39.9%) | 136 (26.0%) | 136 (26.0%) | 102 (19.5%) | 516 (98.5%) |
Lee SW et al., 2020 [25]; Korea | 4785 | ≥18 | N/A | N/A | N/A | N/A | N/A | N/A |
Ramchandaran P et al., 2020 [18]; USA | 295 | >60 | 162 (54.9%) | 209 (70.8%) | 132 (44.7%) | 45 (15.2%) | N/A | 44 (14.9%) |
McKeigue PM et al., 2021 [27]; Scotland | 4251 | N/A | N/A | N/A | 949 (22.3%) | 2649 (62.3%) | 96 (2.3%) | 1430 (33.6%) |
Blanc F et al., 2020 [28]; France | 89 | Mean 84.4 SD 7.9 | 31 (34.8%) | 61 (68.5%) | 36 (40.4%) | 53 (59.6%) | 47 (52.8%) | 15 (16.9%) |
Huh K et al., 2020 [29]; South Korea | 6507 | N/A | 2815 (43.3%) | 1780 (27.4%) | 1562 (24.0%) | 1095 (16.8%) | 749 (11.5%) | 2893 (44.5%) |
Xiang Y et al., 2021 [17]; United Kingdom | 397,000 | Mean 68.1 SD 8.1 | 177,441 (44.7%) | 131,180 (33.0%) | 28,287 (7.1%) | 31,258 (7.9%) | N/A | 69,397 (17.4%) |
Vila-Corcoles A et al., 2021 [30]; Spain | 205 | N/A | 83 (40.5%) | N/A | 69 (33.7%) | 85 (41.5%) | 39 (19.0%) | 42 (20.5%) |